Gene · 26284
ERAL1: Era like 12S mitochondrial rRNA chaperone 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ERAL1: Era like 12S mitochondrial rRNA chaperone 1. Genes, record 26284. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/26284
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O75616 | GTPase Era, mitochondrial | 437 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents11
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 1522 | O75616 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 1522 | O75616 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 27976 | O75616 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 130947 | O75616 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 3623 | O75616 | Espacenet |
| WO 2020043864 A1 | 2020-03-05 | 809 | O75616 | Espacenet |
| JP 2017121240 A | 2017-07-13 | 50132 | O75616 | Espacenet |
| JP 2015518704 A | 2015-07-06 | 50132 | O75616 | Espacenet |
| JP 2002191363 A | 2002-07-09 | 17679 | O75616 | Espacenet |
| JP 2001526914 A | 2001-12-25 | 17 | O75616 | Espacenet |
1 to 10 of 11
See all 11 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants678
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ERAL1 papers | Newest fiscal year |
|---|---|---|---|
| ZIALM000073 | Comparative Analysis Of Completely Sequenced Genomes | 12 | 2025 |
| ZIALM000061 | Finding Protein Sequence Motifs--Methods And Applications | 9 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P30CA142543 | UT Southwestern Medical Center Simmons Comprehensive Cancer Center | 5 | 2025 |
| R35GM118141 | Mitochondrial Biogenesis in Health and Disease | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| ZIALM594244 | Evolutionary Analysis and Comparative Genomics of Protein Superfamilies | 3 | 2025 |
| I01BX001919 | Expanding the efficacy of asparaginase to solid tumors | 2 | 2025 |
| K12HD000850 | Pediatric Scientist Development Program | 2 | 2025 |
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 2 | 2025 |
1 to 10 of 678Source NIH's project files
See all 678 nih grantsPapers1,475
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LDL-C vs Lp(a): What We Know, the "Zero-LDL" Hypothesis, and Where We Stand in the PCSK9 Era. | Cardiol Rev | 2026 | 42773528 | PubTator, text mining | PubMed |
| Cardiomegaly of Unknown Origin: Why Morphology Still Matters in the Genetic Era - A Case of Cardiac Fabry Disease. | Medeni Med J | 2026 | 42756359 | PubTator, text mining | PubMed |
| Phage-encoded NARP3 system rebuilds NAD+ to subvert bacterial immunity. | Sci Adv | 2026 | 42585302 | PubTator, text mining | PubMed |
| Rapid and quantitative measurement of bacteriophage infectivity via fully automated droplet digital PCR. | Nat Commun | 2026 | 42532990 | PubTator, text mining | PubMed |
| Primary hyperoxaluria type 1-current practice in the siRNA era: an ERA Genes & Kidney Working Group survey. | Clin Kidney J | 2026 | 42395860 | PubTator, text mining | PubMed |
| Effect-Based Photoelectrochemical Screening of Estrogenic Activity in Wastewater via Cell-Free ERα-ERE Assembly. | Anal Chem | 2026 | 42342337 | PubTator, text mining | PubMed |
| The mitochondrial GTPase ERAL1 inhibits HBV replication by triggering the MAVS signaling cascade. | J Transl Med | 2026 | 42304389 | PubTator, text mining | PubMed |
| Comprehensive Insights into Perrault Syndrome: Genetic Diversity and Clinical Implications. | Reprod Sci | 2026 | 42283975 | PubTator, text mining | PubMed |
| Progesterone resistance in atypical endometrial hyperplasia: Expression and mechanisms of hormone-responsive molecules. | Medicine (Baltimore) | 2026 | 42065161 | PubTator, text mining | PubMed |
| Antiproliferative Effect of 24-Deoxysericoside From Terminalia macroptera Guill. & Perr. (Combretaceae) Against Breast Carcinoma: In Vitro, Molecular Docking and ADME Assessment. | Cancer Rep (Hoboken) | 2026 | 41946993 | PubTator, text mining | PubMed |
1 to 10 of 1,475
See all 1,475 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/26284
GET https://conductscience.org/api/genes/v1/26284/patents